Q16236 |
NF2L2_HUMAN |
Ataxic disorder [ICD-11: 8A03] |
Q16236 |
NF2L2_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
Q16236 |
NF2L2_HUMAN |
Glaucoma [ICD-11: 9C61] |
Q16236 |
NF2L2_HUMAN |
Lung cancer [ICD-11: 2C25] |
Q16236 |
NF2L2_HUMAN |
Macular degeneration [ICD-11: 9B75] |
Q16236 |
NF2L2_HUMAN |
Melanoma [ICD-11: 2C30] |
Q16236 |
NF2L2_HUMAN |
Mental/behavioural/neurodevelopmental disorder [ICD-11: 6E20-6E8Z] |
Q16236 |
NF2L2_HUMAN |
Pulmonary hypertension [ICD-11: BB01] |
Q16236 |
NF2L2_HUMAN |
Subarachnoid haemorrhage [ICD-11: 8B01] |
Q16236 |
NF2L2_HUMAN |
Urinary system clinical sympton [ICD-11: MF8Y] |
Q16236 |
NF2L2_HUMAN |
Non-alcoholic fatty liver disease [ICD-11: DB92] |
Q16236 |
NF2L2_HUMAN |
Alpha-1-antitrypsin deficiency [ICD-11: 5C5A] |
Q16236 |
NF2L2_HUMAN |
Motor neuron disease [ICD-11: 8B60] |
Q16236 |
NF2L2_HUMAN |
Multiple sclerosis [ICD-11: 8A40] |
P27695 |
APEX1_HUMAN |
Retinopathy [ICD-11: 9B71] |
P27695 |
APEX1_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P27695 |
APEX1_HUMAN |
Ocular cancer [ICD-11: 2D00-2D07] |
P27695 |
APEX1_HUMAN |
Brain cancer [ICD-11: 2A00] |
P27695 |
APEX1_HUMAN |
Melanoma [ICD-11: 2C30] |
P25779 |
CYSP_TRYCR |
Parasitic worm infestation [ICD-11: 1F90] |
P25779 |
CYSP_TRYCR |
Malaria [ICD-11: 1F40-1F45] |
P10828 |
THB_HUMAN |
Hyper-lipoproteinaemia [ICD-11: 5C80] |
P10828 |
THB_HUMAN |
Hypo-thyroidism [ICD-11: 5A00] |
P10828 |
THB_HUMAN |
Inborn lipid metabolism error [ICD-11: 5C52] |
P10828 |
THB_HUMAN |
Skin postprocedural disorder [ICD-11: EL8Y] |
P10828 |
THB_HUMAN |
Thyrotoxicosis [ICD-11: 5A02] |
P37231 |
PPARG_HUMAN |
Pulmonary hypertension [ICD-11: BB01] |
P37231 |
PPARG_HUMAN |
Sjogren syndrome [ICD-11: 4A43] |
P37231 |
PPARG_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P37231 |
PPARG_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P37231 |
PPARG_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P37231 |
PPARG_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P37231 |
PPARG_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P37231 |
PPARG_HUMAN |
Diabetes mellitus [ICD-11: 5A10] |
P37231 |
PPARG_HUMAN |
Glaucoma [ICD-11: 9C61] |
P37231 |
PPARG_HUMAN |
Inborn lipid metabolism error [ICD-11: 5C52] |
P37231 |
PPARG_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P37231 |
PPARG_HUMAN |
Gout [ICD-11: FA25] |
P37231 |
PPARG_HUMAN |
Indeterminate colitis [ICD-11: DD72] |
P37231 |
PPARG_HUMAN |
Multiple sclerosis [ICD-11: 8A40] |
P37231 |
PPARG_HUMAN |
Nicotine use disorder [ICD-11: 6C4A] |
P37231 |
PPARG_HUMAN |
Non-alcoholic fatty liver disease [ICD-11: DB92] |
P37231 |
PPARG_HUMAN |
Opioid use disorder [ICD-11: 6C43] |
P37231 |
PPARG_HUMAN |
Hyper-lipoproteinaemia [ICD-11: 5C80] |
P37231 |
PPARG_HUMAN |
Idiopathic interstitial pneumonitis [ICD-11: CB03] |
P37231 |
PPARG_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P51449 |
RORG_HUMAN |
Autoimmune disease [ICD-11: 4A40-4A45] |
P51449 |
RORG_HUMAN |
Lung cancer [ICD-11: 2C25] |
P51449 |
RORG_HUMAN |
Psoriasis [ICD-11: EA90] |
P51449 |
RORG_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P51449 |
RORG_HUMAN |
Crohn disease [ICD-11: DD70] |
P51449 |
RORG_HUMAN |
Multiple sclerosis [ICD-11: 8A40] |
P51449 |
RORG_HUMAN |
Arterial occlusive disease [ICD-11: BD40] |
P51449 |
RORG_HUMAN |
Liver cancer [ICD-11: 2C12] |
P51449 |
RORG_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |